Laporan Kasus : Acute Respiratory Distress Syndrome (ARDS) pada Pasien Post COVID-19 dengan Fibrosis
DOI:
https://doi.org/10.55606/jikki.v3i3.2027Keywords:
Acute Respiratory Distress Syndrome, Post Covid Pulmonary FibrosisAbstract
. The Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus (SARS- CoV2) has led to a pandemic situation. According to the WHO classification, COVID-19 patients could be classified with severity as uncomplicated illness, mild pneumonia, severe pneumonia, acute respiratory distress syndrome (ARDS), sepsis and septic shock.Case illustration: A 25 year old female, with a chief complaint of shortness of breath and cough, history of cesarean section surgery with indications of severe preeclampsia and hysterectomy for uterine atony. weeks previously the patient was confirmed positive for COVID-19 without symptoms and tested negative through the Polymerase Chain Reaction (PCR) follow up examination. The Chest X-Ray showed the right lung atelectasis, bronchitis and minimal pleural effusion. CT scan of the chest showed a ground glass opacity in almost all bilateral lung segments with septal thickening in according with the picture of COVID pneumonia with cardiomegaly. The patient was intubated and put on a ventilator due to acute respiratory failure and the drugs include antiviral (oseltamivir), chloroquine, antibiotic (meropenem) and steroid (methylprednisolon) intravenous.Discussion: Post COVID-19 fibrosis is one of the emerging complications of COVID 19 pneumonia and ARDS. This case report highlights ARDS in patient with Pulmonary Post Covid-19 and its challenges in diagnosis and treatment. The combination treatment of mechanical ventilation and drugs such as antiviral,chloroquine, antibiotic, steroid intravenous could give the good outcome for the patient of ARDS due to Pulmonary Fibrosis Post COVID - 19
References
WHO Coronavirus (Covid-19) Dashboard. (2021). Accessed: April 4, 2021: https://covid19.who.int/
Guan W, Ni Z, Hu Y, et al.: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-1720. 10.1056/NEJMoa2002032
Ferguson ND, Fan E, Camporota L, et al.: The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012, 38:1573-1582. 10.1007/s00134-012-2682-1
Burnham E.L., Janssen W.J., Riches D.W., Moss M., Downey G.P. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J. 2014;43:276–285.
Liu X., Zhou H., Zhou Y. Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J Infect. 2020;81(1):e95–e97.
Zambon M, Vincent JL: Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest. 2008, 133:1120-1127. 10.1378/chest.07-2134
Yang X, Yu Y, Xu J, et al.: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020, 8:475-481. 10.1016/S2213-2600(20)30079-5
Lechowicz K., Drozdzal S., Machaj F., Rosik J., Szostak B., Zegan-Baranska M. COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection. J Clin Med. 2020
Group R.C., Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L. Dexamethasone in hospitalized patients with Covid-19 - preliminary report. N Engl J Med. 2020
Chavez, S., Long, B., Koyfman, A., and Liang, S. Y. (in press). Coronavirus disease (COVID-19): a primer for emergency physicians. Am. J. Emerg. Med.
Gentile F., Aimo A., Forfori F. COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead. Eur J Prev Cardiol. 2020;27(13):1442–1446.
Jianan L.I. Eur J Phys Rehabil Med. 2020 June;56(3):335–338.
Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. A review of persistent post-COVID syndrome (PPCS). Clinical reviews in allergy & immunology. 2023 Feb;64(1):66-74.
Tale S, Ghosh S, Meitei SP, Kolli M, Garbhapu AK, Pudi S. Post-COVID-19 pneumonia pulmonary fibrosis. QJM: An International Journal of Medicine. 2020 Nov;113(11):837-8.
Patil S, Tandel N, Bhangdia O. Post covid lung fibrosis (PCLF) or post covid lung sequelae (PCLS) in treated case of severe COVID-19 Pneumonia case in Intensive care unit with ventilatory support and home oxygen therapy for twelve weeks. World Journal of Advanced Pharmaceutical and Medical Research. 2023;4(01):030-41.
Vikas M, Choudhary R, Malik V, Pemmaraju A, Peter D. Early experience of nintedanib in COVID-19 ARDS-related pulmonary fibrosis: a case series. Advances in Respiratory Medicine. 2021 Dec 29;89(6):589-96.
Ko RE, Oh DK, Choi SM, Park S, Park JE, Lee JG, Kim YT, Jeon K. Lung transplantation for severe COVID-19-related ARDS. Therapeutic Advances in Respiratory Disease. 2022 Feb;16:17534666221081035.
Sturgill JL, Mayer KP, Kalema AG, Dave K, Mora S, Kalantar A, Carter DJ, Montgomery-Yates AA, Morris PE. Post-intensive care syndrome and pulmonary fibrosis in patients surviving ARDS-pneumonia of COVID-19 and non-COVID-19 etiologies. Scientific Reports. 2023 Apr 21;13(1):6554.
Doane JJ, Hirsch KS, Baldwin JO, Wurfel MM, Pipavath SN, West TE. Progressive pulmonary fibrosis after non-critical covid-19: a case report. The American Journal of Case Reports. 2021;22:e933458-1.
Ambardar SR, Hightower SL, Huprikar NA, Chung KK, Singhal A, Collen JF. Post-COVID-19 pulmonary fibrosis: novel sequelae of the current pandemic. Journal of clinical medicine. 2021 Jun 1;10(11):2452.
Kumar N, Gupta A, Vardhan H, Daga MK. Post-COVID-19 pulmonary fibrosis: an update. Journal of Advanced Research in Medicine (E-ISSN: 2349-7181 & P-ISSN: 2394-7047). 2021 Jun 30;8(2):16-26.
Alhiyari MA, Ata F, Alghizzawi MI, Bilal AB, Abdulhadi AS, Yousaf Z. Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection. IDCases. 2021 Jan 1;23:e01041.
Mohammadi A, Balan I, Yadav S, Matos WF, Kharawala A, Gaddam M, Sarabia N, Koneru SC, Suddapalli SK, Marzban S, Kharawala AM. Post-COVID-19 pulmonary fibrosis. Cureus. 2022 Mar 2;14(3).
Achkar M, Jamal O, Chaaban T. Post-COVID lung disease (s). Annals of Thoracic Medicine. 2022 Jul;17(3):137.
Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of post-acute lung complications of COVID-19. Radiology. 2021 Nov;301(2):E383-95.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jurnal Ilmu Kedokteran dan Kesehatan Indonesia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
